Methylglycol chitosan and a synthetic TLR4 agonist enhance immune responses to influenza vaccine administered sublingually.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Vaccine

• Publication date

  2015-10-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.vaccine.2015.08.086PMID 26392012PMCID PMC4609623
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response

  2016cited by this paper
• Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015–16 Influenza Season

  2015cited by this paper
• Advances in influenza vaccination

  2014cited by this paper
• Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses.

  2014cited by this paper
• Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) — United States, 2014–15 Influenza Season

  2014cited by this paper
• Polymeric penetration enhancers promote humoral immune responses to mucosal vaccines.

  2014cited by this paper
• The immune response of two microbial antigens delivered intradermally, sublingually, or the combination thereof.

  2014cited by this paper
• Buccal and sublingual vaccine delivery

  2014cited by this paper
• Intranasal H5N1 Vaccines, Adjuvanted with Chitosan Derivatives, Protect Ferrets against Highly Pathogenic Influenza Intranasal and Intratracheal Challenge

  2014cited by this paper
• Adjuvant Effects of Chitosan and Calcium Phosphate Particles in an Inactivated Newcastle Disease Vaccine

  2014cited by this paper
• Rabbit nasal immunization against influenza by dry-powder form of chitosan nanospheres encapsulated with influenza whole virus and adjuvants.

  2014cited by this paper
• Intranasal chitosan-DNA vaccines that protect across influenza virus subtypes.

  2014cited by this paper
• Induction of Intestinal Immunity by Mucosal Vaccines As a Means of Controlling HIV Infection

  2014cited by this paper
• Intranasal Vaccination Promotes Detrimental Th17-Mediated Immunity against Influenza Infection

  2014cited by this paper
• Simplifying Influenza Vaccination During Pandemics: Sublingual Priming and Intramuscular Boosting of Immune Responses with Heterologous Whole Inactivated Influenza Vaccine

  2014cited by this paper
• Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines.

  2014cited by this paper
• Evaluation of the Effectiveness and Safety of Chitosan Derivatives as Adjuvants for Intranasal Vaccines

  2013cited by this paper
• Sublingual Delivery of Vaccines for the Induction of Mucosal Immunity

  2013cited by this paper
• Sublingual administration of bacteria-expressed influenza virus hemagglutinin 1 (HA1) induces protection against infection with 2009 pandemic H1N1 influenza virus

  2013cited by this paper
• New vaccines against influenza virus

  2013cited by this paper
• Chitosan Nanoparticle Encapsulated Hemagglutinin-Split Influenza Virus Mucosal Vaccine

  2013cited by this paper
• Correlates of protection against influenza infection in humans--on the path to a universal vaccine?

  2013cited by this paper
• Chitosan-based delivery systems for mucosal vaccines

  2012cited by this paper
• A study of Chitosan and c‐di‐GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine

  2012cited by this paper
• Sublingual Immunization with a Live Attenuated Influenza A Virus Lacking the Nonstructural Protein 1 Induces Broad Protective Immunity in Mice

  2012cited by this paper
• Evaluation of TLR Agonists as Potential Mucosal Adjuvants for HIV gp140 and Tetanus Toxoid in Mice

  2012cited by this paper
• Characterization of neutralizing antibodies in adults after intranasal vaccination with an inactivated influenza vaccine

  2012cited by this paper
• Characterization of the Fungal Microbiota (Mycobiome) in Healthy and Dandruff-Afflicted Human Scalps

  2012cited by this paper
• Sublingual immunization with an engineered Bacillus subtilis strain expressing tetanus toxin fragment C induces systemic and mucosal immune responses in piglets.

  2012cited by this paper
• The mucosal vaccine quandary: Intranasal vs. sublingual immunization against influenza

  2012cited by this paper
• Recent progress in mucosal vaccine development: potential and limitations

  2012cited by this paper
• Sublingual Immunization with M2-Based Vaccine Induces Broad Protective Immunity against Influenza

  2011cited by this paper
• Matrix‐M adjuvanted virosomal H5N1 vaccine confers protection against lethal viral challenge in a murine model

  2011cited by this paper
• Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice.

  2011cited by this paper
• Is the choice of vaccine adjuvant critical for long-term memory development?

  2010cited by this paper
• Sublingual Administration of an Adenovirus Serotype 5 (Ad5)-Based Vaccine Confirms Toll-Like Receptor Agonist Activity in the Oral Cavity and Elicits Improved Mucosal and Systemic Cell-Mediated Responses against HIV Antigens despite Preexisting Ad5 Immunity

  2010cited by this paper
• Mucosal adjuvants and long-term memory development with special focus on CTA1-DD and other ADP-ribosylating toxins

  2010cited by this paper
• Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin

  2009cited by this paper
• Cyclodextrins and chitosan derivatives in sublingual delivery of low solubility peptides: A study using cyclosporin A, alpha-cyclodextrin and quaternary chitosan N-betainate.

  2009cited by this paper
• Mucosal Immunity: Induction, Dissemination, and Effector Functions

  2009cited by this paper
• Trimethyl chitosan and its applications in drug delivery

  2009cited by this paper
• Sublingual vaccination with influenza virus protects mice against lethal viral infection

  2008cited by this paper
• Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice

  2008cited by this paper
• The 'Ethereal' nature of TLR4 agonism and antagonism in the AGP class of lipid A mimetics.

  2008cited by this paper
• Correlates of protection: novel generations of influenza vaccines.

  2008cited by this paper
• Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine.

  2007cited by this paper
• Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs.

  2006cited by this paper
• Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery

  2006cited by this paper
• Mucosal immunity and vaccines

  2005cited by this paper
• Proinflammatory responses in the murine brain after intranasal delivery of cholera toxin: implications for the use of AB toxins as adjuvants in intranasal vaccines.

  2005cited by this paper
• An investigation on the physicochemical properties of chitosan/DNA polyelectrolyte complexes.

  2005cited by this paper
• Secretory IgA antibodies provide cross‐protection against infection with different strains of influenza B virus

  2004cited by this paper
• Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland.

  2004cited by this paper
• Role of IgA versus IgG in the Control of Influenza Viral Infection in the Murine Respiratory Tract1

  2004cited by this paper
• NALT- versus PEYER'S-patch-mediated mucosal immunity

  2004cited by this paper
• New generation of mucosal adjuvants for the induction of protective immunity

  2003cited by this paper
• Enhanced Mucosal Immunoglobulin A Response of Intranasal Adenoviral Vector Human Immunodeficiency Virus Vaccine and Localization in the Central Nervous System

  2003cited by this paper
• Protection Against Influenza Virus Infection in Polymeric Ig Receptor Knockout Mice Immunized Intranasally with Adjuvant-Combined Vaccines

  2002cited by this paper
• A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants.

  2002cited by this paper
• Vaccines for mucosal immunity to combat emerging infectious diseases.

  2000cited by this paper
• Chitosan: a unique polysaccharide for drug delivery.

  1998cited by this paper
• Polyelectrolyte Complex Formation in Highly Aggregating Systems. 1. Effect of Salt: Polyelectrolyte Complex Formation in the Presence of NaCl

  1997cited by this paper
• Mucosal immunity--a major adaptive defence mechanism.

  1997cited by this paper
• Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)

  1994cited by this paper
• Lymphokine control of in vivo immunoglobulin isotype selection.

  1990cited by this paper
• The systemic and mucosal immune response of humans to influenza A virus.

  1989cited by this paper
• Influenza: its control in persons and populations.

  1986cited by this paper
• Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans

  1985cited by this paper

• Emerging trends in viral infection inhibition using a chitosan-based drug delivery system

  2025cites this paper
• Systemic microRNA Delivery Using Polysaccharide-Coated Nanobubbles for Ultrasound-Mediated Therapy of Triple-Negative Breast Cancer.

  2025cites this paper
• Correlations Between Rheology, In Situ Mucosal Retention and In Vivo Immunogenicity Reveal the Potential and Limitations of Mucoadhesive Excipients for Sublingual Vaccine Delivery

  2025influential citation
• Applications of Chitosan in Prevention and Treatment Strategies of Infectious Diseases

  2024cites this paper
• Complexes of an Anionic Surfactant with Chitosan and Its Hydrophobic Derivatives As Disinfectants against SARS-CoV-2

  2023cites this paper
• Oral mucosa immunity: ultimate strategy to stop spreading of pandemic viruses

  2023cites this paper
• Diamino Allose Phosphates: Novel, Potent, and Highly Stable Toll-like Receptor 4 Agonists.

  2023cites this paper
• Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies

  2022cites this paper
• Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies

  2022cites this paper
• Sublingual vaccination and delivery systems.

  2021cites this paper
• An Overview on Chitosan-Based Adjuvant/Vaccine Delivery Systems

  2021cites this paper
• Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection

  2021cites this paper
• Chitosan-drug encapsulation as a potential candidate for COVID-19 drug delivery systems: A review

  2020cites this paper
• Enabling sublingual peptide immunization with molecular self-assemblies.

  2020cites this paper
• Effectiveness of Chitosan Nanoparticles in Development of Pentavalent Clostridial Toxoid Vaccine in Terms of Clinical Pathology Elements and Immunological Responses.

  2020cites this paper
• Engineered Nanoparticle Applications for Recombinant Influenza Vaccines.

  2020cites this paper
• Disruption of nasal bacteria enhances protective immune responses to influenza A virus and SARS-CoV-2 infection in mice

  2020cites this paper
• [Adjuvants of influenza vaccines: new possibilities of using sulphated polysaccharides from marine brown algae.]

  2019cites this paper
• Immunomodulation as a Novel Strategy for Prevention and Treatment of Bordetella spp. Infections

  2019cites this paper
• Co-encapsulation of synthetic lipidated TLR4 and TLR7/8 agonists in the liposomal bilayer results in a rapid, synergistic enhancement of vaccine-mediated humoral immunity.

  2019cites this paper
• Application of Chitosan-Based Formulations in Controlled Drug Delivery

  2019cites this paper
• Dehydroabietyl Glycidyl Ether Grafted Hydroxyethyl Chitosan: Synthesis, Characterization and Physicochemical Properties

  2019cites this paper
• Efficient Mucosal Immunization by Mucoadhesive and pH-Sensitive Polymeric Vaccine Delivery System

  2019cites this paper
• Noninvasive vaccination against infectious diseases

  2018cites this paper
• Biodegradable Polymeric Nanocarrier-Based Immunotherapy in Hepatitis Vaccination.

  2018cites this paper
• Commentary on the Development and Application of Chitosan in Immunochemistry

  2017cites this paper
• CD71 targeting boosts immunogenicity of sublingually delivered influenza haemagglutinin antigen and protects against viral challenge in mice.

  2016cites this paper